spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transcription PDB-id
1i6v
Biological unit* = asymmetric unit, as shown
(*as deduced by PQS)
Main view
    Jmol     Help!  
Contents
Description
Header details
Header records
References
PROCHECK
Protein chains
224 a.a. *
1113 a.a. *
1174 a.a. *
98 a.a. *
Ligands
RFP
Metal ions
_ZN
_MG

* Residue conservation analysis
Tools
Image Generation
AstexViewer™@PDBe
Run PROCHECK
Clefts Calculation
  
Right view Bottom view
PDB id: 1i6v
Name: Transcription
Title: Thermus aquaticus core RNA polymerase-rifampicin complex

Structure:
DNA-directed RNA polymerase. Chain: a, b. Fragment: alpha subunit. DNA-directed RNA polymerase. Chain: c. Fragment: beta subunit. DNA-directed RNA polymerase. Chain: d. Fragment: beta-prime subunit.

Source:
Thermus aquaticus. Organism_taxid: 271. Organism_taxid: 271

Biological unit:
Pentamer (from PQS)

UniProt:
Chains A, B: Q9KWU8 (RPOA_THEAQ)
Pfam   ArchSchema ?
Seq:
Struc:
Seq: 314 a.a.
Struc: 224 a.a.*

Chain C: Q9KWU7 (RPOB_THEAQ)
Pfam   ArchSchema ?
Seq:
Struc:
Seq:
Struc:
Seq:
Struc:
Seq:
Struc:
Seq: 1119 a.a.
Struc: 1113 a.a.*

Chain D: Q9KWU6 (RPOC_THEAQ)
Pfam   ArchSchema ?
Seq:
Struc:
Seq:
Struc:
Seq:
Struc:
Seq:
Struc:
Seq:
Struc:
Seq:
Struc:
Seq: 1524 a.a.
Struc: 1174 a.a.*

Chain E: Q9EVV4 (RPOZ_THEAQ)
Pfam   ArchSchema ?
Seq: 99 a.a.
Struc: 98 a.a.
Key:    PfamA domain
 Secondary structure  CATH domain
* PDB and UniProt seqs differ at 48 residue positions (black crosses)

Enzyme class:
Chains A, B, C, D, E: E.C.2.7.7.6   [IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

Reaction:
Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1) (see diagram below)

Resolution:
3.30Å

R-factor:
0.276

R-free:
0.359

Authors:
E.A.Campbell,N.Korzheva,A.Mustaev,K.Murakami,A.Goldfarb, S.A.Darst

Key ref:
E.A.Campbell et al. (2001). Structural mechanism for rifampicin inhibition of bacterial rna polymerase.. Cell, 104, 901-912. [PubMed id: 11290327] [DOI: 10.1016/S0092-8674(01)00286-0]

Date:
05-Mar-01

Release date:
18-Apr-01

Related entries:
1hqm
1hqm is thermus aquaticus core RNA polymerase
Quick_links
RCSB
PDBe
SRS
MMDB
JenaLib
OCA
PDBWiki
Proteopedia
CATH
SCOP
FSSP
HSSP
PDBSWS
PDBbind
PQS
ProSAT
Whatcheck
Procheck
Go to PROCHECK summary
spacer
spacer
Enzyme reaction for E.C.2.7.7.6


N nucleoside triphosphate
=
N diphosphate
+ {RNA}(N)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site.

 
    Key reference    
 
 
DOI no: 10.1016/S0092-8674(01)00286-0 Cell 104:901-912 (2001)
PubMed id: 11290327  
 
 
Structural mechanism for rifampicin inhibition of bacterial rna polymerase.
E.A.Campbell, N.Korzheva, A.Mustaev, K.Murakami, S.Nair, A.Goldfarb, S.A.Darst.
 
  ABSTRACT  
 
Rifampicin (Rif) is one of the most potent and broad spectrum antibiotics against bacterial pathogens and is a key component of anti-tuberculosis therapy, stemming from its inhibition of the bacterial RNA polymerase (RNAP). We determined the crystal structure of Thermus aquaticus core RNAP complexed with Rif. The inhibitor binds in a pocket of the RNAP beta subunit deep within the DNA/RNA channel, but more than 12 A away from the active site. The structure, combined with biochemical results, explains the effects of Rif on RNAP function and indicates that the inhibitor acts by directly blocking the path of the elongating RNA when the transcript becomes 2 to 3 nt in length.
 
  Selected figure(s)  
 
Figure 4.
Figure 4. Detailed Interactions of Rif with RNAP(a) Stereo view of the Taq RNAP Rif binding pocket complexed with Rif, generated using RIBBONS (Carson, 1991), showing residues that interact directly with the inhibitor. The view is from the top of the RNAP in Figure 3b, above the β subunit, looking down through β to the Rif, but with obscuring parts of β removed. The backbone of the β subunit is shown as a cyan ribbon. Side chains (and backbone atoms of F394) of residues within 4 Šof Rif are shown. Carbon atoms are orange (Rif), magenta (three residues substituted in M. tuberculosis Rif^R clinical isolates with high frequency, see Figure 1), or yellow; oxygen atoms are red; nitrogen atoms are blue. Potential hydrogen bonds between protein atoms and Rif are shown as dashed lines.(b) Schematic drawing of RNAP β subunit interactions with Rif, modified from LIGPLOT (Wallace et al., 1995). Residues forming van der Waals interactions are indicated, those participating in hydrogen bonds are shown in a ball-and-stick representation, with hydrogen bonds depicted as dashed lines. Carbon atoms of the protein are black, while carbon atoms of Rif are orange. Oxygen atoms are red and nitrogen atoms are blue
Figure 6.
Figure 6. Mechanism of RNAP Inhibition by Rif(a) The RNAP active site Mg^2+ (magenta sphere) and the 9 bp RNA/DNA hybrid (from +1 to −8) from a model of the ternary elongation complex (Korzheva et al., 2000) are shown. The RNAP itself and the rest of the nucleic acids are omitted for clarity. The incoming nucleotide substrate at the +1 position is colored green, the −1 and −2 positions, which can be accommodated in the presence of Rif, are colored yellow. The RNA further upstream (−3 to −8), which cannot be accommodated in the presence of Rif, is colored pink. The template strand of the DNA is colored gray. Also shown is a CPK representation of Rif as it would be positioned in its binding site on the β subunit (carbon atoms, orange; oxygen, red; nitrogen, blue). The Rif is partially transparent, illustrating the RNA nucleotides at −3 to −5 that sterically clash. Generated using GRASP (Nicholls et al., 1991).(b) The structure of the minimal scaffold systems with RNA lengths from 3–7 nt (labeled above the RNA chain; Korzheva et al., 2000). The results are presented below as autoradiographs of the radioactive RNAs produced by E. coli (lanes 1–15) or Taq (lanes 16–30) core RNAPs transcribing the minimal scaffolds with the indicated lengths of RNA (“X =â€) and analyzed on a 23% polyacrylamide gel. Lanes 1–10 and 16–25 demonstrate the effect of Rif inhibition of transcription when it was bound by RNAP either before (lanes 1–5 and 16–20) or after (lanes 6–10 and lanes 21–25) addition of the scaffold. Lanes 11–15 and 26–30 show elongation of the same scaffolds in the absence of Rif. The RNA with the critical length of 3 nt, which cannot be elongated by E. coli RNAP in the presence of Rif regardless of the order of Rif and scaffold addition (lanes 1 and 6), is colored red. The RNAs of 4–7 nt (colored green) were extended by E. coli RNAP when added before Rif (lanes 6–10)
 
  The above figures are reprinted by permission from Cell Press: Cell (2001, 104, 901-912) copyright 2001.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19889704 A.R.Hall, V.F.Griffiths, R.C.MacLean, and N.Colegrave (2010).
Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa.
  Proc Biol Sci, 277, 643-650.  
19969540 K.Zhao, M.Liu, and R.R.Burgess (2010).
Promoter and regulon analysis of nitrogen assimilation factor, sigma54, reveal alternative strategy for E. coli MG1655 flagellar biosynthesis.
  Nucleic Acids Res, 38, 1273-1283.  
19376864 M.Dehbi, G.Moeck, F.F.Arhin, P.Bauda, D.Bergeron, T.Kwan, J.Liu, J.McCarty, M.Dubow, and J.Pelletier (2009).
Inhibition of transcription in Staphylococcus aureus by a primary sigma factor-binding polypeptide from phage G1.
  J Bacteriol, 191, 3763-3771.  
19698188 N.Pike, and R.Kingcombe (2009).
Antibiotic treatment leads to the elimination of Wolbachia endosymbionts and sterility in the diplodiploid collembolan Folsomia candida.
  BMC Biol, 7, 54.  
19266075 R.C.MacLean, and A.Buckling (2009).
The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa.
  PLoS Genet, 5, e1000406.  
19329639 Y.Chai, and S.C.Winans (2009).
The chaperone GroESL enhances the accumulation of soluble, active TraR protein, a quorum-sensing transcription factor from Agrobacterium tumefaciens.
  J Bacteriol, 191, 3706-3711.  
19419240 Y.Korkhin, U.M.Unligil, O.Littlefield, P.J.Nelson, D.I.Stuart, P.B.Sigler, S.D.Bell, and N.G.Abrescia (2009).
Evolution of Complex RNA Polymerases: The Complete Archaeal RNA Polymerase Structure.
  PLoS Biol, 7, e102.
PDB codes: 2waq 2wb1
18787125 A.Feklistov, V.Mekler, Q.Jiang, L.F.Westblade, H.Irschik, R.Jansen, A.Mustaev, S.A.Darst, and R.H.Ebright (2008).
Rifamycins do not function by allosteric modulation of binding of Mg2+ to the RNA polymerase active center.
  Proc Natl Acad Sci U S A, 105, 14820-14825.  
18235446 A.Hirata, B.J.Klein, and K.S.Murakami (2008).
The X-ray crystal structure of RNA polymerase from Archaea.
  Nature, 451, 851-854.
PDB codes: 2pa8 2pmz
19052235 B.K.Cho, C.L.Barrett, E.M.Knight, Y.S.Park, and B.Ã.˜.Palsson (2008).
Genome-scale reconstruction of the Lrp regulatory network in Escherichia coli.
  Proc Natl Acad Sci U S A, 105, 19462-19467.  
18394163 C.Sala, F.Forti, F.Magnoni, and D.Ghisotti (2008).
The katG mRNA of Mycobacterium tuberculosis and Mycobacterium smegmatis is processed at its 5' end and is stabilized by both a polypurine sequence and translation initiation.
  BMC Mol Biol, 9, 33.  
18997387 D.M.Rothstein, R.J.Suchland, M.Xia, C.K.Murphy, and W.E.Stamm (2008).
Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniae.
  J Antibiot (Tokyo), 61, 489-495.  
  18461657 D.R.Beckler, S.Elwasila, G.Ghobrial, J.F.Valentine, and S.A.Naser (2008).
Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease.
  World J Gastroenterol, 14, 2723-2730.  
18430157 E.Varhimo, K.Savijoki, H.Jefremoff, J.Jalava, A.Sukura, and P.Varmanen (2008).
Ciprofloxacin induces mutagenesis to antibiotic resistance independent of UmuC in Streptococcus uberis.
  Environ Microbiol, 10, 2179-2183.  
18349144 J.Baysarowich, K.Koteva, D.W.Hughes, L.Ejim, E.Griffiths, K.Zhang, M.Junop, and G.D.Wright (2008).
Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr.
  Proc Natl Acad Sci U S A, 105, 4886-4891.
PDB code: 2hw2
18559647 J.R.O'Connor, M.A.Galang, S.P.Sambol, D.W.Hecht, G.Vedantam, D.N.Gerding, and S.Johnson (2008).
Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
  Antimicrob Agents Chemother, 52, 2813-2817.  
19023549 N.Durán, M.A.Alvarenga, E.C.Da Silva, P.S.Melo, and P.D.Marcato (2008).
Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
  Arch Pharm Res, 31, 1509-1516.  
18684700 P.R.Cortes, G.E.Piñas, A.G.Albarracin Orio, and J.R.Echenique (2008).
Subinhibitory concentrations of penicillin increase the mutation rate to optochin resistance in Streptococcus pneumoniae.
  J Antimicrob Chemother, 62, 973-977.  
17921309 C.E.César, and M.Llosa (2007).
TrwC-mediated site-specific recombination is controlled by host factors altering local DNA topology.
  J Bacteriol, 189, 9037-9043.  
17917240 C.K.Murphy, E.Karginova, D.Sahm, and D.M.Rothstein (2007).
In vitro activity of novel rifamycins against gram-positive clinical isolates.
  J Antibiot (Tokyo), 60, 572-576.  
17912677 D.M.Rothstein, J.van Duzer, A.Sternlicht, and S.C.Gilman (2007).
Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections.
  Arch Pharm (Weinheim), 340, 517-529.  
17184328 E.G.Medrano, and A.A.Bell (2007).
Role of Pantoea agglomerans in opportunistic bacterial seed and boll rot of cotton (Gossypium hirsutum) grown in the field.
  J Appl Microbiol, 102, 134-143.  
17513475 E.Varhimo, K.Savijoki, J.Jalava, O.P.Kuipers, and P.Varmanen (2007).
Identification of a novel streptococcal gene cassette mediating SOS mutagenesis in Streptococcus uberis.
  J Bacteriol, 189, 5210-5222.  
17641648 M.Suzuki, L.Mao, and M.Inouye (2007).
Single protein production (SPP) system in Escherichia coli.
  Nat Protoc, 2, 1802-1810.  
17569663 V.Nagarajavel, S.Madhusudan, S.Dole, A.R.Rahmouni, and K.Schnetz (2007).
Repression by binding of H-NS within the transcription unit.
  J Biol Chem, 282, 23622-23630.  
16377701 A.J.O'Neill, T.Huovinen, C.W.Fishwick, and I.Chopra (2006).
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence.
  Antimicrob Agents Chemother, 50, 298-309.  
17110578 A.N.Kapanidis, E.Margeat, S.O.Ho, E.Kortkhonjia, S.Weiss, and R.H.Ebright (2006).
Initial transcription by RNA polymerase proceeds through a DNA-scrunching mechanism.
  Science, 314, 1144-1147.  
16495239 C.K.Murphy, S.Mullin, M.S.Osburne, J.van Duzer, J.Siedlecki, X.Yu, K.Kerstein, M.Cynamon, and D.M.Rothstein (2006).
In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.
  Antimicrob Agents Chemother, 50, 827-834.  
16914440 E.Kashkina, M.Anikin, T.H.Tahirov, S.N.Kochetkov, D.G.Vassylyev, and D.Temiakov (2006).
Elongation complexes of Thermus thermophilus RNA polymerase that possess distinct translocation conformations.
  Nucleic Acids Res, 34, 4036-4045.  
16980465 G.Yim, F.de la Cruz, G.B.Spiegelman, and J.Davies (2006).
Transcription modulation of Salmonella enterica serovar Typhimurium promoters by sub-MIC levels of rifampin.
  J Bacteriol, 188, 7988-7991.  
16717405 H.Yoneyama, and R.Katsumata (2006).
Antibiotic resistance in bacteria and its future for novel antibiotic development.
  Biosci Biotechnol Biochem, 70, 1060-1075.  
16629670 K.V.Newell, D.P.Thomas, D.Brekasis, and M.S.Paget (2006).
The RNA polymerase-binding protein RbpA confers basal levels of rifampicin resistance on Streptomyces coelicolor.
  Mol Microbiol, 60, 687-696.  
16621791 S.F.Holmes, T.J.Santangelo, C.K.Cunningham, J.W.Roberts, and D.A.Erie (2006).
Kinetic investigation of Escherichia coli RNA polymerase mutants that influence nucleotide discrimination and transcription fidelity.
  J Biol Chem, 281, 18677-18683.  
16524917 V.Trinh, M.F.Langelier, J.Archambault, and B.Coulombe (2006).
Structural perspective on mutations affecting the function of multisubunit RNA polymerases.
  Microbiol Mol Biol Rev, 70, 12-36.  
16109958 C.D.Herring, M.Raffaelle, T.E.Allen, E.I.Kanin, R.Landick, A.Z.Ansari, and B.Ã.˜.Palsson (2005).
Immobilization of Escherichia coli RNA polymerase and location of binding sites by use of chromatin immunoprecipitation and microarrays.
  J Bacteriol, 187, 6166-6174.  
15692574 E.A.Campbell, O.Pavlova, N.Zenkin, F.Leon, H.Irschik, R.Jansen, K.Severinov, and S.A.Darst (2005).
Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase.
  EMBO J, 24, 674-682.
PDB codes: 1ynj 1ynn
16204929 F.d.e. .J.dos Santos, V.F.Ximenes, L.M.da Fonseca, O.M.de Faria Oliveira, and I.L.Brunetti (2005).
Horseradish peroxidase-catalyzed oxidation of rifampicin: reaction rate enhancement by co-oxidation with anti-inflammatory drugs.
  Biol Pharm Bull, 28, 1822-1826.  
15542547 J.L.Knight, V.Mekler, J.Mukhopadhyay, R.H.Ebright, and R.M.Levy (2005).
Distance-restrained docking of rifampicin and rifamycin SV to RNA polymerase using systematic FRET measurements: developing benchmarks of model quality and reliability.
  Biophys J, 88, 925-938.  
15917517 M.J.Ferrándiz, C.Ardanuy, J.Liñares, J.M.García-Arenzana, E.Cercenado, A.Fleites, and A.G.de la Campa (2005).
New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals.
  Antimicrob Agents Chemother, 49, 2237-2245.  
16127086 M.Xia, R.J.Suchland, J.A.Carswell, J.Van Duzer, D.K.Buxton, K.Brown, D.M.Rothstein, and W.E.Stamm (2005).
Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatis.
  Antimicrob Agents Chemother, 49, 3974-3976.  
15805525 M.Xu, Y.N.Zhou, B.P.Goldstein, and D.J.Jin (2005).
Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics.
  J Bacteriol, 187, 2783-2792.  
15836776 N.Kawamura, K.Kurokawa, T.Ito, H.Hamamoto, H.Koyama, C.Kaito, and K.Sekimizu (2005).
Participation of Rho-dependent transcription termination in oxidative stress sensitivity caused by an rpoB mutation.
  Genes Cells, 10, 477-487.  
15793146 N.Zenkin, A.Kulbachinskiy, I.Bass, and V.Nikiforov (2005).
Different rifampin sensitivities of Escherichia coli and Mycobacterium tuberculosis RNA polymerases are not explained by the difference in the beta-subunit rifampin regions I and II.
  Antimicrob Agents Chemother, 49, 1587-1590.  
15728912 R.J.Suchland, A.Bourillon, E.Denamur, W.E.Stamm, and D.M.Rothstein (2005).
Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.
  Antimicrob Agents Chemother, 49, 1120-1126.  
15958167 R.M.Anthony, A.R.Schuitema, I.L.Bergval, T.J.Brown, L.Oskam, and P.R.Klatser (2005).
Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency.
  Ann Clin Microbiol Antimicrob, 4, 9.  
16078308 S.Reckel, F.Löhr, and V.Dötsch (2005).
In-cell NMR spectroscopy.
  Chembiochem, 6, 1601-1606.  
15791687 Y.Xiong, X.Wu, and T.Mahmud (2005).
A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.
  Chembiochem, 6, 834-837.  
15606780 A.Kulbachinskiy, A.Feklistov, I.Krasheninnikov, A.Goldfarb, and V.Nikiforov (2004).
Aptamers to Escherichia coli core RNA polymerase that sense its interaction with rifampicin, sigma-subunit and GreB.
  Eur J Biochem, 271, 4921-4931.  
15583262 C.Marianelli, F.Ciuchini, M.Tarantino, P.Pasquali, and R.Adone (2004).
Genetic bases of the rifampin resistance phenotype in Brucella spp.
  J Clin Microbiol, 42, 5439-5443.  
15294890 C.Prins, S.G.Cresawn, and R.C.Condit (2004).
An isatin-beta-thiosemicarbazone-resistant vaccinia virus containing a mutation in the second largest subunit of the viral RNA polymerase is defective in transcription elongation.
  J Biol Chem, 279, 44858-44871.  
15265034 E.Sarubbi, F.Monti, E.Corti, A.Miele, and E.Selva (2004).
Mode of action of the microbial metabolite GE23077, a novel potent and selective inhibitor of bacterial RNA polymerase.
  Eur J Biochem, 271, 3146-3154.  
15060052 H.Maughan, B.Galeano, and W.L.Nicholson (2004).
Novel rpoB mutations conferring rifampin resistance on Bacillus subtilis: global effects on growth, competence, sporulation, and germination.
  J Bacteriol, 186, 2481-2486.  
15020457 M.Kim, E.Wolff, T.Huang, L.Garibyan, A.M.Earl, J.R.Battista, and J.H.Miller (2004).
Developing a genetic system in Deinococcus radiodurans for analyzing mutations.
  Genetics, 166, 661-668.  
15109717 M.Sasaki, and Y.Kurusu (2004).
Analysis of spontaneous base substitutions generated in mutator strains of Bacillus subtilis.
  FEMS Microbiol Lett, 234, 37-42.  
15469515 S.Duigou, S.D.Ehrlich, P.Noirot, and M.F.Noirot-Gros (2004).
Distinctive genetic features exhibited by the Y-family DNA polymerases in Bacillus subtilis.
  Mol Microbiol, 54, 439-451.  
14604986 S.F.Tolić-Nørrelykke, A.M.Engh, R.Landick, and J.Gelles (2004).
Diversity in the rates of transcript elongation by single RNA polymerase molecules.
  J Biol Chem, 279, 3292-3299.  
15503140 S.Mennecier, G.Coste, P.Servant, A.Bailone, and S.Sommer (2004).
Mismatch repair ensures fidelity of replication and recombination in the radioresistant organism Deinococcus radiodurans.
  Mol Genet Genomics, 272, 460-469.  
14612444 T.Inaoka, K.Takahashi, H.Yada, M.Yoshida, and K.Ochi (2004).
RNA polymerase mutation activates the production of a dormant antibiotic 3,3'-neotrehalosadiamine via an autoinduction mechanism in Bacillus subtilis.
  J Biol Chem, 279, 3885-3892.  
12556219 D.M.Rothstein, A.D.Hartman, M.H.Cynamon, and B.I.Eisenstein (2003).
Development potential of rifalazil.
  Expert Opin Investig Drugs, 12, 255-271.  
12566399 D.W.Selinger, R.M.Saxena, K.J.Cheung, G.M.Church, and C.Rosenow (2003).
Global RNA half-life analysis in Escherichia coli reveals positional patterns of transcript degradation.
  Genome Res, 13, 216-223.  
14576436 I.Artsimovitch, C.Chu, A.S.Lynch, and R.Landick (2003).
A new class of bacterial RNA polymerase inhibitor affects nucleotide addition.
  Science, 302, 650-654.  
12756229 T.J.Santangelo, R.A.Mooney, R.Landick, and J.W.Roberts (2003).
RNA polymerase mutations that impair conversion to a termination-resistant complex by Q antiterminator proteins.
  Genes Dev, 17, 1281-1292.  
12821487 U.Dreses-Werringloer, I.Padubrin, L.Köhler, and A.P.Hudson (2003).
Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis.
  Antimicrob Agents Chemother, 47, 2316-2318.  
12730602 V.Epshtein, and E.Nudler (2003).
Cooperation between RNA polymerase molecules in transcription elongation.
  Science, 300, 801-805.  
12970184 V.Epshtein, F.Toulmé, A.R.Rahmouni, S.Borukhov, and E.Nudler (2003).
Transcription through the roadblocks: the role of RNA polymerase cooperation.
  EMBO J, 22, 4719-4727.  
12486074 W.L.Ng, K.M.Kazmierczak, G.T.Robertson, R.Gilmour, and M.E.Winkler (2003).
Transcriptional regulation and signature patterns revealed by microarray analyses of Streptococcus pneumoniae R6 challenged with sublethal concentrations of translation inhibitors.
  J Bacteriol, 185, 359-370.  
11796364 A.J.Vogler, J.D.Busch, S.Percy-Fine, C.Tipton-Hunton, K.L.Smith, and P.Keim (2002).
Molecular analysis of rifampin resistance in Bacillus anthracis and Bacillus cereus.
  Antimicrob Agents Chemother, 46, 511-513.  
12486015 B.W.Trautinger, and R.G.Lloyd (2002).
Modulation of DNA repair by mutations flanking the DNA channel through RNA polymerase.
  EMBO J, 21, 6944-6953.  
11751823 J.E.Bandow, H.Brötz, and M.Hecker (2002).
Bacillus subtilis tolerance of moderate concentrations of rifampin involves the sigma(B)-dependent general and multiple stress response.
  J Bacteriol, 184, 459-467.  
  11784853 J.F.Kugel, and J.A.Goodrich (2002).
Translocation after synthesis of a four-nucleotide RNA commits RNA polymerase II to promoter escape.
  Mol Cell Biol, 22, 762-773.  
12401787 J.Yuzenkova, M.Delgado, S.Nechaev, D.Savalia, V.Epshtein, I.Artsimovitch, R.A.Mooney, R.Landick, R.N.Farias, R.Salomon, and K.Severinov (2002).
Mutations of bacterial RNA polymerase leading to resistance to microcin j25.
  J Biol Chem, 277, 50867-50875.  
12016307 K.S.Murakami, S.Masuda, E.A.Campbell, O.Muzzin, and S.A.Darst (2002).
Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex.
  Science, 296, 1285-1290.
PDB code: 1l9z
11904365 S.A.Darst, N.Opalka, P.Chacon, A.Polyakov, C.Richter, G.Zhang, and W.Wriggers (2002).
Conformational flexibility of bacterial RNA polymerase.
  Proc Natl Acad Sci U S A, 99, 4296-4301.  
12180928 S.A.Joyce, and C.J.Dorman (2002).
A Rho-dependent phase-variable transcription terminator controls expression of the FimE recombinase in Escherichia coli.
  Mol Microbiol, 45, 1107-1117.  
11987181 T.Heyduk, and A.Niedziela-Majka (2001).
Fluorescence resonance energy transfer analysis of escherichia coli RNA polymerase and polymerase-DNA complexes.
  Biopolymers, 61, 201-213.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.